A quick throwback into EASD2024, held in Madrid in 9th-13th September: This year, EASD brought together a large and engaged audience of more than 12,000 people, with particular interest in Type 1 Diabetes. The event, designed to bridge the gap between scientific discoveries and public health, featured key presentations and discussions about the disease. HEDIMED…
Novel Technologies used in HEDIMED Volatile organic compounds (VOCs) are substances that readily evaporate in our ordinary living environment. This means that they have a high vapour pressure at room temperature and low boiling point, which facilitates their volatility and makes them responsible for odours and smells. VOCs are a diverse group of compounds derived…
Novel Technologies used in HEDIMED One of the main aims of the HEDIMED project is to investigate what is behind the epidemic of immune-related diseases, and there is a wide range of different exposures under research. Among other things, several infections have been associated with autoimmune diseases or the mechanisms behind them. For example, some…
Novel technologies used in Hedimed Amidst the rising tide of allergies and sensitivities, such as reactions to specific foods and pollen, CSEM stands as a beacon of innovation through the HEDIMED project. Guided by the expertise of Loïc Burr and Stefano Cattaneo at CSEM’s Landquart research facilities in Switzerland, this transformative technology is poised to…
In HEDIMED, we are developing and using new technologies to advance research and science. Over time, we will introduce these technologies in depth in dedicated blog posts. Here is an overview of what is to come: CSEM’s cutting-edge portable solution for allergy testing The new allergy testing technology developed by HEDIMED partner CSEM is a portable…
A workshop on ‘Exposome expectations in child health’ was held on 16th-20th October in Leiden, Netherlands. This was an intensive and interactive event for slightly over 20 people from multiple sectors of exposome research. Wide-ranging expertise was gathered! HEDIMED took advantage of being involved in this transdisciplinary, important, and future-oriented work. The exposome research on…
In the middle of autumn, we had the pleasure of getting together in Thessaloniki, Greece! The HEDIMED consortium meeting was held on 11th-13th October with the great help of our Thessaloniki partner Gnomon. One of the landmarks of Thessaloniki: The White Tower and the Waterfront promenade Prior to the meeting, three HEDIMED subgroups took a…
The annual meeting of EHEN (European Human Exposome Network) took place in Leuven 30th of May – the 1st of June. Over a hundred members of nine EHEN projects had an opportunity to communicate, network, and disseminate their research. Thank you for your work all organizing team members! It was great that online attending was…
The increasing incidence of type 1 diabetes has caused concern in the Western world during recent decades. Type 1 diabetes is an immune-mediated disease and genetics and environment, including diet, microbial infections and other factors, all are suspected to have a role in disease development. Exposure to these non-genetic environmental factors is called the exposome. In…
Project consortium meeting took place in 8th-9th December ’22 in Malmo, Sweden. The 2-day meeting consisted of workshops, small working groups, and updates from laboratories and the project in general. This time we managed to gather more than 60 attendees in-place. Toxicant, celiac disease as well as exosome group meetings took place already in pre-meeting…